COST OF ILLNESS PASIEN DIABETES MELLITUS TIPE 2 JKN NON PBI DI INSTALASI RAWAT INAP  RUMAH SAKIT ISLAM SULTAN AGUNG SEMARANG PERIODE JANUARI-DESEMBER 2022

Finda Hamidah; Yustisia Dian Advistasari; Wulan Kartika Sari

doi:10.30591/pjif.v12i3.5706

COST OF ILLNESS PASIEN DIABETES MELLITUS TIPE 2 JKN NON PBI DI INSTALASI RAWAT INAP RUMAH SAKIT ISLAM SULTAN AGUNG SEMARANG PERIODE JANUARI-DESEMBER 2022

Finda Hamidah, Yustisia Dian Advistasari, Wulan Kartika Sari

Abstract

Diabetes mellitus is a group of metabolic diseases characterized by hyperglycemia resulting from defects in insulin secretion. Diabetes Mellitus is classified into several types, namely type 1 diabetes mellitus, type 2 diabetes mellitus, gestational diabetes mellitus, and other types of diabetes mellitus. Treatment of diabetes mellitus requires a large amount of money because it requires a lifetime of treatment and frequent co-morbidities. The purpose of this study was to determine the characteristics of patients with type 2 diabetes mellitus and to determine the average direct medical costs in patients with type 2 diabetes mellitus with or without comorbidities at the inpatient installation of RSI Sultan Agung Semarang in 2022. The results of this study were 84 patients who met the inclusion criteria with a total of 43 female patients and 41 male patients. The most dominant age range is in the age range of 55-65 years. The type 2 diabetes mellitus patients with comorbidities with a total of 80 patients with 34 types of comorbidities of IDR 4,202 .124. Type 2 diabetes mellitus patients with the most comorbidities were type 2 diabetes mellitus patients with hypertension comorbidities with a total of 17 patients.

Keywords

Disease Cost, Type 2 Diabetes Mellitus, RSI Sultan Agung Semarang in 2022

Full Text:

References

E. Fitri, T. M. Andayani, and E. Suparniati, “Cost Analysis of Diabetes Melitus,” J. Manag. Pharm. Pract., vol. 5, no. 1, pp. 61–66, 2015.

S. I. Imelda, “Faktor-Faktor Yang Mempengaruhi Terjadinya diabetes Melitus di Puskesmas Harapan Raya Tahun 2018,” Sci. J., vol. 8, no. 1, pp. 28–39, 2019, doi: 10.35141/scj.v8i1.406.

S. Soelistijo, “Pedoman Pengelolaan dan Pencegahan Diabetes Melitus Tipe 2 Dewasa di Indonesia 2021,” Glob. Initiat. Asthma, p. 46, 2021, [Online]. Available: www.ginasthma.org.

M. S. Rusdi, “Hipoglikemia Pada Pasien Diabetes Melitus,” J. Syifa Sci. Clin. Res., vol. 2, no. September, pp. 83–90, 2020, [Online]. Available: http://ejurnal.ung.ac.id/index.php/jsscr,

Kemenkes RI, “Hasil Riset Kesehatan Dasar Tahun 2018,” Kementrian Kesehat. RI, vol. 53, no. 9, pp. 1689–1699, 2018.

Fatimah NR, “Diabetes Mellitus Tipe 2,” Indones. J. Pharm., vol. 4, no. 5, pp. 93–101, 2015, doi: 10.14499/indonesianjpharm27iss2pp74.

E. Fitri, T. M. Andayani, and E. S. Suparniati, “Analisis Biaya Penyakit Diabates Mellitus (Cost Analysis of Diabetes Melitus),” J. Manag. Pharm. Pract., vol. 5, no. 1, pp. 61–66, 2015, [Online]. Available: https://jurnal.ugm.ac.id/jmpf/article/view/29634/17743

Depkes RI, Klasifikasi umur menurut kategori. Jakarta, 2009.

2020 Komariah, “Dengan Kadar Gula Darah Puasa Pada Pasien Diabetes Melitus Tipe 2 Di Klinik Pratama Rawat Jalan,” J. Kesehat. Kusuma Husada, vol. 11, no. 1, pp. 41–50, 2020.

DOI: https://doi.org/10.30591/pjif.v12i3.5706